| Keyword search (3,940 papers available) | ![]()  | 
Author(s): Mohammadi H; Zargaran SJ; Khajehpour H; Adibi I; Rahimiforoushani A; Karimi S; Serej ND; Alam NR;...
Short-term memory (STM) temporarily stores sensory information, critical for synaptic plasticity, memory, and learning, and is regulated by the glutamate-gated NMDA receptor. While the frontal and ...
Article GUID: 41171530
Author(s): Barbaux L; Cross NE; Perrault AA; Es-Sounni M; Desrosiers C; Clerc D; Andriamampionona F; Lussier D; Tannenbaum C; Guimond A; Grenier S; Gou...
Objectives: Our objective was to assess the effect of cognitive-behavioral therapy for insomnia (CBTi) on subjective and objective sleep quality (including sleep spindles) and cogn...
Article GUID: 41092866
Author(s): Phelps J; Singh M; McCreary CR; Dallaire-Théroux C; Stein RG; Potvin-Jutras Z; Guan DX; Wu JD; Metz A; Smith EE;...
Cerebral small vessel disease (CSVD) can manifest as brain lesions visible on magnetic resonance imaging, including white matter hyperintensities (WMH), cerebral microbleeds (CMB), perivascular spa...
Article GUID: 41080650
Author(s): Nutter S; Waugh R; McEachran E; Toor A; Shelley J; Alberga AS; Forhan M; Kirk SF; Nagpal TS; Patton I; Ramos Salas X; Russell-Mayhew S;...
Weight stigma negatively impacts people with higher weights across the lifespan as well as social contexts and can lead to weight discrimination. As weight is not a protected identity in Canadian h...
Article GUID: 41029703
Author(s): Villeneuve S; Poirier J; Breitner JCS; Tremblay-Mercier J; Remz J; Raoult JM; Yakoub Y; Gallego-Rudolf J; Qiu T; Fajardo Valdez A; Mohammedi...
The PResymptomatic EValuation of Experimental or Novel Treatments for Alzheimer's Disease (PREVENT-AD) is an investigator-driven study that was created in 2011 and enrolled cognitively normal o...
Article GUID: 41020412
Author(s): MacNeil S; da Estrela C; Caldwell W; Gouin JP;
Objective: A parent's ability to self-regulate influences parenting practices. Child-related stressors may deplete parent's self-regulatory capacities. However, this effect may be moderated by the marital context within which stressful parent-child ...
Article GUID: 40972822
Author(s): Pieruccini-Faria F; Son S; Zou G; Almeida QJ; Middleton LE; Bray NW; Lussier M; Shoemaker JK; Speechley M; Liu-Ambrose T; Burhan AM; Camicio...
Background: Older adults with mild cognitive impairment (MCI) have a higher risk of gait impairments and falls; yet, the effects of multimodal interventions, including combinations of exercises wit...
Article GUID: 40966614
Author(s): Jäger AP; Steele CJ; Dreyer FR; Osterloh MR; Sadlon A; Nikulin V; Mohr B; Pulvermüller F;
Background: Intensive language-action therapy treats language deficits and depressive symptoms in chronic poststroke aphasia, yet the underlying neural mechanisms remain underexplored. Long-range temporal correlations (LRTCs) in blood oxygenation level-depe...
Article GUID: 40927858
Author(s): Saputra ST; Van Hulst A; Henderson M; Brugiapaglia S; Faustini C; Kakinami L;
Background: A dual-energy x-ray absorptiometry (DXA)-derived phenotype classification based on fat mass and muscle mass has been developed for adults. We extended this to a paediatric population. Methods: Children's (= 17 years) DXA data in NHANES (n =...
Article GUID: 40878792
			| Title: | Synergistic effects of exercise, cognitive training and vitamin D on gait performance and falls in mild cognitive impairment-secondary outcomes from the SYNERGIC trial | 
| Authors: | Pieruccini-Faria F, Son S, Zou G, Almeida QJ, Middleton LE, Bray NW, Lussier M, Shoemaker JK, Speechley M, Liu-Ambrose T, Burhan AM, Camicioli R, Li KZH, Fraser S, Berryman N, Bherer L, Montero-Odasso M, | 
| Link: | https://pubmed.ncbi.nlm.nih.gov/40966614/ | 
| DOI: | 10.1093/ageing/afaf242 | 
| Category: | |
| PMID: | 40966614 | 
| Dept Affiliation: | SOH
						
							 1 Department of Medicine, Division of Geriatric Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. 2 Parkwood Institute, Gait and Brain Laboratory, London, Ontario, Canada. 3 Western University, Schulich School of Medicine and Dentistry, Department of Epidemiology and Biostatistics, London, Ontario, Canada. 4 Alimentiv Inc., London, Ontario, Canada. 5 Carespace Health and Wellness Neurodegeneration Clinics, Waterloo, Ontario, Canada. 6 Department of Kinesiology and Health Sciences, University of Waterloo, Waterloo, Ontario, Canada. 7 Schlegel-UW Research Institute for Aging, Waterloo, Ontario, Canada. 8 Recovery and Performance Laboratory, Biomedical Sciences, Faculty of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada. 9 Centre de Recherche de l'Institut Universitaire de Gériatrie de Montréal, Université de Montréal, Montreal, Quebec, Canada. 10 École de Réadaptation, Faculté de Médecine, Université de Montréal, Montreal, Québec, Canada. 11 School of Kinesiology, University of Western Ontario, London, Ontario, Canada. 12 Department of Epidemiology and Biostatistics, and Schulich Interfaculty Program in Public Health, Western University, London, Ontario, Canada. 13 Department of Physical Therapy, University of British Columbia, Vancouver, British Columbia, Canada. 14 Djavad Mowafaghian Centre for Brain Health, Vancouver Coastal Health Research Institute, Vancouver, British Columbia, Canada. 15 Centre for Aging SMART at Vancouver Coastal Health, Vancouver Coastal Health Research Institute, Vancouver, British Columbia, Canada. 16 Ontario Shores Centre for Mental Health Sciences, Whitby, Ontario, Canada. 17 Department of Psychiatry, Temerity Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. 18 Department of Medicine and Neuroscience and Mental Health Institute, University of Alberta, Edmonton, Alberta, Canada. 19 Department of Psychology, Concordia University, Montréal, Québec, Canada. 20 Interdisciplinary School of Health Sciences, University of Ottawa, Ottawa, Ontario, Canada. 21 Département des Sciences de l'Activité Physique, Université du Québec à Montréal, Montréal, Québec, Canada. 22 Institut national du sport du Québec, Montréal, Québec, Canada. 23 Centre de Recherche de l'Institut Universitaire de Gériatrie de Montréal, Montréal, Québec, Canada. 24 Centre de Recherche, Institut de Cardiologie de Montréal, Montréal, Québec, Canada. 25 Département de Médecine, Université de Montréal, Montréal, Québec, Canada.  | 
				
Description:  | 
					
						 Background: Older adults with mild cognitive impairment (MCI) have a higher risk of gait impairments and falls; yet, the effects of multimodal interventions, including combinations of exercises with cognitive training, on improving their mobility remain unclear. Objectives: To investigate the synergistic effects of aerobic-resistance exercise combined with cognitive training, with or without vitamin D supplementation, on gait performance and falls risk in older adults with MCI. Methods: The effect of 20 weeks of aerobic-resistance exercise, cognitive training, and Vitamin D supplementation (10 000 IU 3×/week) on gait and falls in older adults with MCI was evaluated in the SYNERGIC trial, using a fractional factorial design. Assessments were conducted at baseline, 6-month endpoint (after intervention) and 12-month endpoint (follow-up). Eligible participants were between the ages of 65 and 84 years with MCI enrolled from 19 September 2016 to 7 April 2020. Main outcomes of interest for gait performance were gait speed and gait variability changes, whilst for falls were incidental falls and incidental injurious falls. Results: Amongst 161 participants, the four exercise-based arms improved gait speed (+7.5 cm/s, P < .001) and reduced falls (incidence rate ratios (IRR) = 0.65, 95% confidence interval (CI): 0.32-1.42, P = .25) and injurious falls (IRR = 0.38, 95% CI: 0.15-1.05, P = .05) at 6-month endpoint. Falls reduction reached statistical significance (IRR = 0.28, 95% CI: 0.13-0.64, P = .002) at 12-month endpoint. Exercises combined with cognitive training showed the greatest gains in gait speed at 6-month endpoint (P < .001) and in reducing falls at 12-month endpoint (IRR = 0.24, 95% CI: 0.05-0.77, P = .02) compared to the control. Vitamin D did not enhance outcomes and increased gait variability, a marker of instability. Conclusion: Aerobic-resistance exercise combined with sequential computerised cognitive training improved gait performance at 6 months and decreased the risk of falls and injuries at 12 months in older adults with MCI. The addition of vitamin D did not produce benefits.  |